Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

STSSW

Sharps Technology (STSSW)

Sharps Technology Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:STSSW
일자시간출처헤드라인심볼기업
2024/06/1321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
2024/06/1321:30GlobeNewswire Inc.Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC FacilityNASDAQ:STSSWSharps Technology Inc
2024/06/0606:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:STSSWSharps Technology Inc
2024/06/0521:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
2024/06/0521:30GlobeNewswire Inc.Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow DepositNASDAQ:STSSWSharps Technology Inc
2024/06/0506:03Edgar (US Regulatory)Form 253G3 -NASDAQ:STSSWSharps Technology Inc
2024/06/0422:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
2024/06/0319:07Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:STSSWSharps Technology Inc
2024/05/3121:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
2024/05/3121:30GlobeNewswire Inc.Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.NASDAQ:STSSWSharps Technology Inc
2024/05/3113:15Edgar (US Regulatory)Form QUALIF - Notice of Qualification [Regulation A]NASDAQ:STSSWSharps Technology Inc
2024/05/3101:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
2024/05/3023:12Edgar (US Regulatory)Form 1-A/A - Offering Statement [Regulation A]: [Amend]NASDAQ:STSSWSharps Technology Inc
2024/05/3021:30GlobeNewswire Inc.Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.NASDAQ:STSSWSharps Technology Inc
2024/05/3006:27Edgar (US Regulatory)Form 1-A/A - Offering Statement [Regulation A]: [Amend]NASDAQ:STSSWSharps Technology Inc
2024/05/3001:47Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:STSSWSharps Technology Inc
2024/05/2902:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
2024/05/2902:00GlobeNewswire Inc.Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured SyringesNASDAQ:STSSWSharps Technology Inc
2024/05/2505:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSWSharps Technology Inc
2024/05/2206:27Edgar (US Regulatory)Form 1-A - Offering Statement [Regulation A]NASDAQ:STSSWSharps Technology Inc
2024/05/1505:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STSSWSharps Technology Inc
2024/03/0722:00GlobeNewswire Inc.Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery SystemsNASDAQ:STSSWSharps Technology Inc
2024/02/2122:00GlobeNewswire Inc.Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in ColombiaNASDAQ:STSSWSharps Technology Inc
2024/02/1704:42GlobeNewswire Inc.Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery SystemsNASDAQ:STSSWSharps Technology Inc
2024/01/1823:00GlobeNewswire Inc.Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery SystemsNASDAQ:STSSWSharps Technology Inc
2023/09/2922:54GlobeNewswire Inc.Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private PlacementNASDAQ:STSSWSharps Technology Inc
2023/09/2823:52GlobeNewswire Inc.Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron PharmaceuticalsNASDAQ:STSSWSharps Technology Inc
2023/09/2801:03GlobeNewswire Inc.UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesNASDAQ:STSSWSharps Technology Inc
2023/09/2722:14GlobeNewswire Inc.Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesNASDAQ:STSSWSharps Technology Inc
2023/09/2621:30GlobeNewswire Inc.Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron PharmaceuticalsNASDAQ:STSSWSharps Technology Inc
 검색 관련기사 보기:NASDAQ:STSSW